Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Pseudoprogression after radiation therapies for low grade glioma in children and adults: A systematic review and meta-analysis.

Lu VM, Welby JP, Laack NN, Mahajan A, Daniels DJ.

Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33003-8. doi: 10.1016/j.radonc.2019.07.013. [Epub ahead of print]

PMID:
31431375
2.

Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy.

Ludmir EB, Mahajan A, Paulino AC, Jones JY, Ketonen LM, Su JM, Grosshans DR, McAleer MF, McGovern SL, Lassen-Ramshad YA, Adesina AM, Dauser RC, Weinberg JS, Chintagumpala MM.

Neuro Oncol. 2019 May 6;21(5):686-695. doi: 10.1093/neuonc/noz042.

PMID:
30753704
3.

Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.

Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA.

J Neurooncol. 2019 Mar;142(1):69-77. doi: 10.1007/s11060-018-03063-1. Epub 2018 Nov 28.

PMID:
30488294
4.

Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.

Abrigo JM, Fountain DM, Provenzale JM, Law EK, Kwong JS, Hart MG, Tam WWS.

Cochrane Database Syst Rev. 2018 Jan 22;1:CD011551. doi: 10.1002/14651858.CD011551.pub2. Review.

5.

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma.

Bronk JK, Guha-Thakurta N, Allen PK, Mahajan A, Grosshans DR, McGovern SL.

Clin Transl Radiat Oncol. 2018 Jan 12;9:30-34. doi: 10.1016/j.ctro.2018.01.002. eCollection 2018 Feb.

6.

Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.

Carceller F, Fowkes LA, Khabra K, Moreno L, Saran F, Burford A, Mackay A, Jones DT, Hovestadt V, Marshall LV, Vaidya S, Mandeville H, Jerome N, Bridges LR, Laxton R, Al-Sarraj S, Pfister SM, Leach MO, Pearson AD, Jones C, Koh DM, Zacharoulis S.

J Neurooncol. 2016 Aug;129(1):109-21. doi: 10.1007/s11060-016-2151-8. Epub 2016 May 14.

PMID:
27180091
7.

Pseudoprogression in pediatric low-grade glioma after irradiation.

Tsang DS, Murphy ES, Lucas JT Jr, Lagiou P, Acharya S, Merchant TE.

J Neurooncol. 2017 Nov;135(2):371-379. doi: 10.1007/s11060-017-2583-9. Epub 2017 Jul 27.

PMID:
28752498
8.

Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].

LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep.

9.

First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.

Remick JS, Schonewolf C, Gabriel P, Doucette A, Levin WP, Kucharczuk JC, Singhal S, Pechet TTV, Rengan R, Simone CB 2nd, Berman AT.

Clin Lung Cancer. 2017 Jul;18(4):364-371. doi: 10.1016/j.cllc.2016.12.009. Epub 2017 Jan 5.

PMID:
28162946
10.

H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications.

Lu VM, Marek T, Gilder HE, Puffer RC, Raghunathan A, Spinner RJ, Daniels DJ.

J Neurooncol. 2019 Sep;144(3):433-443. doi: 10.1007/s11060-019-03247-3. Epub 2019 Jul 24. Review.

PMID:
31342317
11.

Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis.

Lu VM, Welby JP, Mahajan A, Laack NN, Daniels DJ.

Childs Nerv Syst. 2019 May;35(5):739-746. doi: 10.1007/s00381-019-04118-y. Epub 2019 Mar 16. Review.

PMID:
30879125
12.

Model-based cost-effectiveness analysis of external beam radiation therapy for the treatment of localized prostate cancer: a systematic review.

Abreha SK.

Cost Eff Resour Alloc. 2019 May 21;17:10. doi: 10.1186/s12962-019-0178-3. eCollection 2019. Review.

13.

Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.

Abbasi AW, Westerlaan HE, Holtman GA, Aden KM, van Laar PJ, van der Hoorn A.

Clin Neuroradiol. 2018 Sep;28(3):401-411. doi: 10.1007/s00062-017-0584-x. Epub 2017 May 2.

14.

A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.

Fang P, Mick R, Deville C, Both S, Bekelman JE, Christodouleas JP, Guzzo TJ, Tochner Z, Hahn SM, Vapiwala N.

Cancer. 2015 Apr 1;121(7):1118-27. doi: 10.1002/cncr.29148. Epub 2014 Nov 25.

15.

Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas.

Sarmiento JM, Venteicher AS, Patil CG.

Cochrane Database Syst Rev. 2015 Jun 29;(6):CD009229. doi: 10.1002/14651858.CD009229.pub2. Review.

16.

Radiotherapy Treatments for Head and Neck Cancer Update [Internet].

Ratko TA, Douglas GW, de Souza JA, Belinson SE, Aronson N.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec.

17.

A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy.

Dennis ER, Bussiere MR, Niemierko A, Lu MW, Fullerton BC, Loeffler JS, Shih HA.

Technol Cancer Res Treat. 2013 Feb;12(1):1-9. doi: 10.7785/tcrt.2012.500276. Epub 2012 Jul 10.

PMID:
22775339
18.

Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.

Parikh RR, Rhome R, Hug E, Tsai H, Cahlon O, Chon B, Goenka A.

Clin Lung Cancer. 2016 Sep;17(5):362-366. doi: 10.1016/j.cllc.2016.05.019. Epub 2016 Jun 8.

PMID:
27372386
19.

Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.

Hirano Y, Onozawa M, Hojo H, Motegi A, Zenda S, Hotta K, Moriya S, Tachibana H, Nakamura N, Kojima T, Akimoto T.

Radiat Oncol. 2018 Feb 9;13(1):23. doi: 10.1186/s13014-018-0966-5.

20.

Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.

Shiraishi Y, Xu C, Yang J, Komaki R, Lin SH.

Radiother Oncol. 2017 Oct;125(1):48-54. doi: 10.1016/j.radonc.2017.07.034. Epub 2017 Sep 13.

PMID:
28917586

Supplemental Content

Support Center